3sfi: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.== | ==Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.== | ||
<StructureSection load='3sfi' size='340' side='right' caption='[[3sfi]], [[Resolution|resolution]] 2.31Å' scene=''> | <StructureSection load='3sfi' size='340' side='right'caption='[[3sfi]], [[Resolution|resolution]] 2.31Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3sfi]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[3sfi]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SFI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3SFI FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3SF:5,5,5-TRIFLUORO-1-{4-[3-(1,3-THIAZOL-2-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDIN-1-YL}PENTAN-1-ONE'>3SF</scene> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.31Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3SF:5,5,5-TRIFLUORO-1-{4-[3-(1,3-THIAZOL-2-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDIN-1-YL}PENTAN-1-ONE'>3SF</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3sfi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3sfi OCA], [https://pdbe.org/3sfi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3sfi RCSB], [https://www.ebi.ac.uk/pdbsum/3sfi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3sfi ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/ETHR_MYCTU ETHR_MYCTU] Involved in the repression of the monooxygenase EthA which is responsible of the formation of the active metabolite of ethionamide (ETH).<ref>PMID:10869356</ref> <ref>PMID:10944230</ref> | ||
==See Also== | |||
*[[Tetracycline repressor protein 3D structures|Tetracycline repressor protein 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Baulard | [[Category: Large Structures]] | ||
[[Category: Blondiaux | [[Category: Mycobacterium tuberculosis]] | ||
[[Category: Brodin | [[Category: Baulard AR]] | ||
[[Category: Christophe | [[Category: Blondiaux N]] | ||
[[Category: Desroses | [[Category: Brodin P]] | ||
[[Category: Flament | [[Category: Christophe T]] | ||
[[Category: Flipo | [[Category: D prez B]] | ||
[[Category: Jeon | [[Category: Desroses M]] | ||
[[Category: Lecat-Guillet | [[Category: Flament MP]] | ||
[[Category: Leroux | [[Category: Flipo M]] | ||
[[Category: Locht | [[Category: Jeon HK]] | ||
[[Category: Mathys | [[Category: Lecat-Guillet N]] | ||
[[Category: Piveteau | [[Category: Leroux F]] | ||
[[Category: Siepmann | [[Category: Locht C]] | ||
[[Category: Soror | [[Category: Mathys V]] | ||
[[Category: Villemagne | [[Category: Piveteau C]] | ||
[[Category: Villeret | [[Category: Siepmann J]] | ||
[[Category: Willand | [[Category: Soror SH]] | ||
[[Category: Wintjens | [[Category: Villemagne B]] | ||
[[Category: Wohlkonig | [[Category: Villeret V]] | ||
[[Category: Willand N]] | |||
[[Category: Wintjens R]] | |||
[[Category: Wohlkonig A]] | |||
Latest revision as of 12:55, 14 March 2024
Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.
| ||||||||||||